In the United States, enterprise AI has moved well beyond the initial trial stages. Chief Financial Officers now demand measurable returns on investment, corporate boards require demonstrable risk management, and regulatory bodies expect controls aligned with established risk frameworks. Within this environment, AI leaders consistently grapple with a pivotal question: Is it better to develop AI capabilities internally, purchase solutions from external vendors, or adopt a hybrid approach?
The reality is that there is no one-size-fits-all solution. The optimal strategy depends heavily on the specific context and the overall portfolio of AI applications. Rather than framing the decision as a simple “build versus buy” dilemma, organizations should evaluate each AI use case based on its strategic importance, regulatory demands, and operational readiness.
Understanding the U.S. Regulatory and Market Landscape
Unlike the European Union’s comprehensive AI Act, the U.S. regulatory environment is characterized by a sector-specific, enforcement-driven approach. Key frameworks and guidelines shaping AI adoption in American enterprises include:
- NIST AI Risk Management Framework (RMF): Serving as the primary federal guideline, this framework influences procurement policies and vendor risk assessments across government agencies and private companies alike.
- NIST AI 600-1 (Generative AI Profile): Establishes refined standards for evaluating generative AI, focusing on hallucination testing, ongoing monitoring, and documentation.
- Financial Sector Regulations: Including Federal Reserve’s SR 11-7 on model risk, FDIC and FFIEC guidance, and the OCC’s scrutiny of AI models used in underwriting and risk assessment.
- Healthcare Compliance: Governed by HIPAA and FDA oversight, particularly for AI algorithms applied in clinical settings.
- Federal Trade Commission (FTC): Enforces transparency and disclosure requirements to prevent deceptive AI practices.
- Securities and Exchange Commission (SEC): Mandates public companies to disclose material AI-related risks, such as bias, cybersecurity vulnerabilities, and data privacy concerns.
For U.S. enterprises, the absence of a unified AI regulatory statute means that boards and regulators will rigorously evaluate your AI governance, model oversight, and vendor risk management. This reality intensifies the need for a well-substantiated and defensible Build vs Buy strategy.
Strategic Approaches: Build, Buy, or Combine?
From a leadership perspective, the decision framework can be summarized as follows:
- Build: Opt for internal development when AI capabilities are core to your competitive edge, involve highly sensitive data (such as PHI, PII, or financial information), or require seamless integration with proprietary systems.
- Buy: Choose vendor solutions when the AI application is standardized, rapid deployment is critical, or external providers offer compliance assurances that your organization cannot easily replicate.
- Blend: Most enterprises find success with a hybrid model-leveraging vendor platforms for foundational AI services (including multi-model management, safety protocols, and compliance documentation) while customizing the “last mile” components like prompt engineering, data retrieval, orchestration, and domain-specific evaluations.
A Comprehensive 10-Factor Model to Guide Build vs Buy Decisions
To move beyond subjective opinions, implement a structured scoring system that evaluates each factor on a scale from 1 to 5, weighted according to your organization’s strategic priorities:
| Factor | Weight | Build Preference | Buy Preference |
|---|---|---|---|
| 1. Strategic differentiation | 15% | AI is a core product differentiator | Enhances general productivity |
| 2. Data sensitivity and residency | 10% | Handles PHI/PII or regulated datasets | Vendor complies with HIPAA/SOC 2 standards |
| 3. Regulatory exposure | 10% | Subject to SR 11-7, HIPAA, FDA regulations | Vendor offers mapped compliance controls |
| 4. Time-to-value | 10% | Acceptable timeline: 3-6 months | Requires delivery within weeks |
| 5. Customization requirements | 10% | Highly domain-specific and workflow-tailored | Configurable off-the-shelf solutions suffice |
| 6. Integration complexity | 10% | Deep embedding into legacy or ERP systems | Standard connectors are adequate |
| 7. Talent and operational maturity | 10% | Established LLMOps and platform teams | Preference for vendor-managed hosting |
| 8. Total cost of ownership (3 years) | 10% | Infrastructure amortized, reusable across teams | Vendor’s pricing model is more economical |
| 9. Performance and scalability | 7.5% | Requires low latency or burst capacity control | Standard service-level agreements suffice |
| 10. Vendor lock-in and portability | 7.5% | Need for open standards and model portability | Comfortable with vendor exit terms |
Decision guidelines:
- Build: If the build score surpasses the buy score by 20% or more.
- Buy: If the buy score exceeds the build score by 20% or more.
- Blend: If the scores fall within a ±20% range.
This quantitative approach transforms subjective debates into objective, transparent discussions suitable for board-level reporting.
Accurately Calculating Total Cost of Ownership Over Three Years
A frequent pitfall in U.S. enterprises is comparing short-term subscription fees with long-term build expenses. Effective decision-making requires comparing equivalent timeframes and cost components.
Components of Build TCO (36 months):
- Internal engineering resources (AI platform engineers, ML engineers, site reliability engineers, security teams)
- Cloud infrastructure costs (GPU/CPU usage for training and inference, autoscaling, layered services)
- Data management pipelines (ETL processes, data labeling, continuous evaluation, adversarial testing)
- Monitoring and observability tools (vector databases, evaluation datasets, pipeline monitoring)
- Compliance activities (NIST RMF audits, SOC 2 readiness, HIPAA compliance reviews, penetration testing)
- Data egress and replication fees across cloud regions
Components of Buy TCO (36 months):
- Subscription or licensing fees, including user seats
- Usage-based charges (token consumption, API calls, context window size)
- Integration and change management costs
- Additional features (proprietary retrieval-augmented generation, evaluation tools, safety layers)
- Vendor compliance certifications and deliverables (SOC 2, HIPAA BAAs, NIST mappings)
- Exit-related expenses, notably cloud egress fees and data migration costs
When Building In-House Makes Sense in the U.S. Market
Ideal scenarios for internal development include:
- Proprietary intellectual property: AI models that drive underwriting decisions, risk scoring, or fraud detection and are central to revenue generation.
- Strict data governance: Situations where protected health information, personally identifiable information, or trade secrets cannot be exposed to external vendors, even under HIPAA BAAs.
- Complex system integration: AI solutions that must be deeply embedded into claims processing, trading platforms, or enterprise resource planning systems that external providers cannot easily access.
Potential challenges include:
- Ongoing compliance demands requiring detailed evidence rather than just policies.
- Difficulty recruiting and retaining experienced LLMOps engineers in a competitive U.S. labor market.
- Hidden costs related to adversarial testing, observability, and evaluation pipelines that may exceed initial budget estimates.
When Purchasing Vendor Solutions Is Preferable
Best-fit use cases for buying include:
- Standardized functions: Tasks such as automated note-taking, customer support ticket deflection, or baseline code generation.
- Urgent deployment: When executive leadership requires AI capabilities to be operational within a single fiscal quarter.
- Vendor compliance advantages: Established U.S. vendors increasingly comply with NIST RMF, SOC 2, HIPAA, and some are pursuing ISO/IEC 42001 certification.
Risks to consider:
- Vendor lock-in: Some providers restrict access to embeddings or retrieval functions through proprietary APIs.
- Cost unpredictability: Token-based billing can cause budget overruns unless strict rate limits are enforced.
- Exit expenses: Cloud egress fees and platform migration costs can significantly impact ROI; contracts should include clear data portability and exit provisions.
The Hybrid Model: The Emerging Standard for U.S. Enterprises in 2025
Among Fortune 500 companies, the prevailing approach is a blended model that combines the strengths of both build and buy strategies:
- Purchase: Core platform capabilities such as governance frameworks, audit trails, multi-model routing, role-based access control, data loss prevention, and compliance attestations.
- Develop internally: Custom “last mile” components including data retrieval layers, tool integrations, domain-specific evaluation datasets, hallucination detection tests, and industry-specific safeguards.
This approach enables scalability while maintaining control over sensitive intellectual property and satisfying board-level oversight requirements.
Essential Due Diligence for AI Leaders
When engaging vendors, verify:
- Certifications: ISO/IEC 42001, SOC 2, and alignment with NIST RMF.
- Data governance: HIPAA Business Associate Agreements, data retention policies, data minimization, redaction practices, and regional data segregation.
- Exit terms: Explicit contractual language on data portability and negotiated relief on egress fees.
- Service level agreements: Performance metrics including latency, throughput, U.S. data residency guarantees, and bias/safety evaluation deliverables.
When building internally, focus on:
- Governance: Implement NIST AI RMF principles-govern, map, measure, and manage.
- Architecture: Design multi-model orchestration layers to avoid vendor lock-in and establish comprehensive observability pipelines covering tracing, cost monitoring, and hallucination metrics.
- Talent: Assemble dedicated LLMOps teams with embedded evaluation and security expertise.
- Cost management: Employ request batching, optimize retrieval processes, and implement strategies to minimize data egress.
Executive Decision-Making Flowchart
- Does this AI capability provide a competitive advantage within the next 12 to 24 months?
- Yes → Lean toward building internally.
- No → Consider purchasing from vendors.
- Is your organization’s governance maturity aligned with NIST AI RMF?
- Yes → Favor building.
- No → Opt for a blended approach: buy vendor guardrails and build last-mile customizations.
- Would vendor compliance documentation expedite regulatory approval?
- Yes → Lean toward buying or blending.
- No → Build to meet compliance requirements.
- Does a three-year total cost of ownership analysis favor internal amortization over subscription fees?
- Internal costs lower → Build.
- Vendor costs lower → Buy.
Case Study: AI in U.S. Healthcare Insurance
Scenario: Automating claims review and explanation of benefits.
- Strategic importance: Moderate-focused on operational efficiency relative to competitors.
- Data sensitivity: Protected Health Information (PHI), governed by HIPAA.
- Regulatory environment: Oversight by HHS and potential FDA regulation for clinical decision support tools.
- Integration complexity: Requires tight coupling with legacy claims processing systems.
- Time-to-value: Acceptable within six months.
- Internal capabilities: Mature data pipelines but limited experience with LLMOps.
Recommended approach:
- Adopt a blended strategy: Utilize a U.S.-based vendor platform with HIPAA BAA and SOC 2 Type II certifications for foundational LLM and governance functions.
- Develop in-house custom components such as retrieval layers, adaptation for medical coding standards (CPT/ICD), and specialized evaluation datasets.
- Align oversight and documentation with the NIST AI RMF to satisfy board audit committees.
Key Recommendations for AI Leaders
- Implement a quantitative, weighted evaluation framework for each AI use case to generate audit-ready evidence for boards and regulators.
- Prepare for hybrid AI environments where vendor platforms provide core capabilities and internal teams retain control over critical customizations.
- Ensure all build and buy decisions comply with NIST AI RMF, SOC 2, ISO/IEC 42001, and relevant U.S. sector-specific regulations such as HIPAA and SR 11-7.
- Always conduct a thorough three-year total cost of ownership analysis that includes cloud egress and migration costs.
- Negotiate clear exit and data portability clauses in all vendor contracts upfront.
In 2025, the Build vs Buy decision for U.S. enterprises transcends ideology. It demands strategic resource allocation, rigorous governance, and disciplined execution. AI leaders who adopt this structured decision-making framework will not only accelerate AI deployment but also fortify their organizations against regulatory challenges and board-level scrutiny.
